Antifungal formulation

Details Antifungal formulation Antifungal formulation

1994-08-17

1996-05-21

Dodson, Shelley A.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

514847, A61K 3116

Patent

active

055190596

ABSTRACT:
Disclosed is a topical antifungal formulation including a mixture of isopropyl alcohol, isopropyl myristate and polyethylene glycol or propylene glycol; and a pharmaceutically effective amount of tolnaftate. The formulation provides a solution of tolnaftate which is penetrating, emollient, and non-oily or greasy, non-irritating and rapidly drying. Optionally, aloe vera, vitamin E succinate and witch hazel may be included.

REFERENCES:
patent: 2257106 (1941-09-01), Christiansen
Pascher, Dermatologic Formulary, 2nd edition, 1957, pp. 28, 29, 31-35 and 42-44.
Merck Index, 9th edition, 1976, p. 1224, #9216.
Glycols, Union Carbide Chemicals Co., 1958, pp. 15 & 16.

Affiliated with

Also associated with

Rating

Antifungal formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antifungal formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antifungal formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2038413